Manisha Shah
Overview
Explore the profile of Manisha Shah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
4173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Contraceptive Care Visit Objectives and Outcomes: Evidence From Burkina Faso, Pakistan, and Tanzania
Moucheraud C, Wollum A, Brooks M, Shah M, Gipson J, Wagner Z
Stud Fam Plann
. 2024 Dec;
55(4):315-332.
PMID: 39627833
Globally, care experiences of the growing population of contraceptive users are not well-understood. We leverage a large client dataset (n = 71,602) from three countries (Burkina Faso, Pakistan, and Tanzania)...
2.
Cameron L, Gertler P, Shah M, Alzua M, Martinez S, Patil S
J Dev Econ
. 2024 Nov;
159:102990.
PMID: 39583182
We examine the impacts of a sanitation program designed to eliminate open defecation in at-scale randomized field experiments in four countries: India, Indonesia, Mali, and Tanzania. The programs - all...
3.
Tripathi P, Kadam N, Sharma B, Shah M, Vijayakumar V, Kuppusamy M
JCEM Case Rep
. 2024 Nov;
2(12):luae210.
PMID: 39544889
Diabetes mellitus significantly affects survival in patients with renal cell carcinoma undergoing nephrectomy, requiring personalized care. This case involved a 64-year-old man with type 2 diabetes (T2D) who underwent radical...
4.
Schwarz E, Benner B, Wesolowski R, Quiroga D, Good L, Sun S, et al.
JCI Insight
. 2024 Nov;
9(21).
PMID: 39513363
BACKGROUNDInhibition of Bruton's tyrosine kinase with ibrutinib blocks the function of myeloid-derived suppressor cells (MDSC). The combination of ibrutinib and nivolumab was tested in patients with metastatic solid tumors.METHODSSixteen patients...
5.
Gautam L, Shah M, Khadka Mishra D, Dahal P, Gautam S
PLOS Glob Public Health
. 2024 Sep;
4(9):e0003298.
PMID: 39325708
Gender-based violence (GBV) is a major global public health challenge in the 21st century that poses a serious impact on women's health and well-being. Therefore, this study aimed to assess...
6.
Mehta J, Chatterjee S, Shah M
J Environ Manage
. 2024 Sep;
369:122252.
PMID: 39222584
Microbial Fuel Cells (MFCs) are a sophisticated and advanced system that uses exoelectrogenic microorganisms to generate bioenergy. Predicting performance outcomes under experimental settings is challenging due to the intricate interactions...
7.
Moucheraud C, Wollum A, Awan M, Dow W, Friedman W, Koulidiati J, et al.
Contracept Reprod Med
. 2024 Jul;
9(1):34.
PMID: 38978108
Beyond Bias was an intervention introduced in Burkina Faso, Pakistan and Tanzania, with the aim of reducing health worker bias toward young, unmarried and nulliparous women seeking family planning services....
8.
Shah M, Arumugam S
Mol Divers
. 2024 Jul;
28(4):2263-2287.
PMID: 38954070
Cardiovascular disease is a chronic inflammatory disease with high mortality rates. TNF-alpha is pro-inflammatory and associated with the disease, but current medications have adverse effects. Therefore, efficient inhibitors are urgently...
9.
Wollum A, Moucheraud C, Gipson J, Friedman W, Shah M, Wagner Z
Soc Sci Med
. 2024 Apr;
348:116826.
PMID: 38581812
Provider bias based on age, marital status, and parity may be a barrier to quality contraceptive care. However, the extent to which bias leads to disparities in care quality is...
10.
Sukrithan V, Kim L, Sipos J, Goyal A, Zhou Y, Addison D, et al.
Case Rep Endocrinol
. 2023 Nov;
2023:8841696.
PMID: 37941892
A subset of patients with differentiated thyroid carcinoma develop radioiodine refractory (RAIR) incurable disease, which typically has a poor prognosis. The multitargeted tyrosine kinase inhibitor lenvatinib has demonstrated significant improvements...